CODX

NASDAQ open

Co-Diagnostics

0.95 USD
-0.19-16.60%
盘后 1.17 0.00%
2026-09-16
市值
$5.88M
市盈率
EPS
-19.36
股息率
52 周区间
0.94 – 46.50
成交量
1.46M
Beta
2.85
目标价
52W 低 0.9452W 高 46.50
价格走势

公司简介

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In...